The FDA is looking into whether hair loss, aspiration and suicidal thoughts may be side effects of GLP-1 receptor agonists, a popular class of weight-loss drugs.
Read the full post on Becker's Hospital Review - Healthcare News
FDA probes hair loss, other potential weight-loss drug side effects
